[PDF][PDF] Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants
Latent replication-competent HIV-1 persists in individuals on long-term antiretroviral therapy
(ART). We developed the Full-Length Individual Proviral Sequencing (FLIPS) assay to …
(ART). We developed the Full-Length Individual Proviral Sequencing (FLIPS) assay to …
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
…, DE Dwyer, KM Edwards, BA Horsburgh… - Nature …, 2022 - nature.com
Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection
with the most severe disease in the young and elderly. Non-pharmaceutical interventions …
with the most severe disease in the young and elderly. Non-pharmaceutical interventions …
[HTML][HTML] High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies
Objective: The contribution of HLA-DR+ memory CD4+ T cells to the HIV reservoir during
prolonged antiretroviral therapy is unclear as these cells are commonly excluded when …
prolonged antiretroviral therapy is unclear as these cells are commonly excluded when …
Cellular activation, differentiation, and proliferation influence the dynamics of genetically intact proviruses over time
BA Horsburgh, B Hiener, K Fisher, E Lee… - The Journal of …, 2022 - academic.oup.com
Human immunodeficiency virus (HIV) persists in cells despite antiretroviral therapy; however,
the influence of cellular mechanisms such as activation, differentiation, and proliferation …
the influence of cellular mechanisms such as activation, differentiation, and proliferation …
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
…, V Mathivanan, BA Horsburgh… - The Journal of …, 2022 - Am Soc Clin Investig
Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of CD4 + T
cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular …
cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular …
[HTML][HTML] Novel Hendra virus variant detected by sentinel surveillance of horses in Australia
We identified and isolated a novel Hendra virus (HeV) variant not detected by routine testing
from a horse in Queensland, Australia, that died from acute illness with signs consistent with …
from a horse in Queensland, Australia, that died from acute illness with signs consistent with …
Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant
…, EJ Annand, BA Horsburgh… - Proceedings of the …, 2022 - National Acad Sciences
Hendra virus (HeV) and Nipah virus (NiV) are deadly zoonotic Henipaviruses (HNVs)
responsible for recurrent outbreaks in humans and domestic species of highly fatal (50 to 95%) …
responsible for recurrent outbreaks in humans and domestic species of highly fatal (50 to 95%) …
Amplification of near full-length HIV-1 proviruses for next-generation sequencing
The Full-Length Individual Proviral Sequencing (FLIPS) assay is an efficient and high-throughput
method designed to amplify and sequence single, near full-length (intact and defective)…
method designed to amplify and sequence single, near full-length (intact and defective)…
[HTML][HTML] Novel variant Hendra virus genotype 2 infection in a horse in the greater Newcastle region, New South Wales, Australia
In October 2021, the first contemporary detection of Hendra virus genotype 2 (HeV-g2) was
made by veterinary priority disease investigation in a horse near Newcastle, New South …
made by veterinary priority disease investigation in a horse near Newcastle, New South …
Measuring HIV persistence on antiretroviral therapy
BA Horsburgh, S Palmer - HIV Vaccines and Cure: The Path Towards …, 2018 - Springer
In order to determine if an eradication strategy for HIV is effective, it will be important to measure
persistent replication-competent virus, the current barrier to a cure. Various assays are …
persistent replication-competent virus, the current barrier to a cure. Various assays are …
